Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) Share Price Rises by 11.62%

Ambalal Sarabhai Enterprises Ltd. Share Price rose by 11.62% today, reaching Rs 34.48, with a market cap of Rs 238.02 crore.

Ambalal Sarabhai Enterprises Ltd. Share Price experienced a significant rise today, increasing by 11.62% to reach Rs 34.48. The company's market capitalisation now stands at Rs 238.02 crore, reflecting its position in the healthcare sector, specifically within the pharmaceuticals and drugs industry. This substantial gain in share price highlights the company's current market dynamics and investor interest.

Today's price action is noteworthy as it aligns with the company's recent performance and market positioning. The increase in share price is not attributed to a specific catalyst based on the available data, but it underscores the company's presence in a competitive industry. Investors and analysts will be keen to explore the underlying factors contributing to this movement, including technical indicators and fundamental metrics that may provide further insights into the company's trajectory.

Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 34.48
Previous Close	Rs 30.89
Today's Change	+Rs 3.59 (+11.62%)
Day Open	Rs 31.45
Day High	Rs 34.75
Day Low	Rs 31.22
Current Volume (BSE)	39,651
BSE Traded Volume	39,651
NSE Traded Volume	2,36,092
Combined NSE + BSE Volume	2,75,743
Turnover	Rs 0.14 crore
Market Capitalisation	Rs 238.02 crore
Market Cap Category	Micro Cap

Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) traded at Rs 34.48. versus the previous close of Rs 30.89, a rise of 11.62%. The stock opened at Rs 31.45, reached Rs 34.75, touched Rs 31.22. Reported volume was 39,651.

Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 238.02 crore
P/E Ratio	13.3x
P/B Ratio	1.49x
ROE	48.74%
ROCE	45.53%
EPS	Rs 2.32
Dividend Yield	0%

Ambalal Sarabhai Enterprises Ltd. was valued at a P/E ratio of 13.3x, a P/B ratio of 1.49x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 48.74% and ROCE of 45.53%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 2.32, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

Ambalal Sarabhai Enterprises Ltd. presents a compelling fundamental profile within the healthcare sector. The company's market capitalisation is Rs 238.02 crore, positioning it as a micro-cap entity. Its price-to-earnings (P/E) ratio is 13.3, which is relatively low compared to the industry average of 80.39, indicating a potentially undervalued status in the market.

The company's price-to-book (P/B) ratio is 1.49, slightly below the industry median of 1.81, suggesting a fair valuation relative to its book value. With a robust return on equity (ROE) of 48.74% and return on capital employed (ROCE) of 45.53%, Ambalal Sarabhai demonstrates strong profitability and efficient capital utilisation. The earnings per share (EPS) is Rs 2.32, reflecting the earnings attributable to each share.

Despite a zero dividend yield, the company's financial metrics indicate a solid foundation for growth and investor interest. The absence of dividends may be offset by the company's reinvestment strategies aimed at enhancing shareholder value. Overall, the fundamental analysis underscores the company's potential within the competitive pharmaceuticals and drugs industry.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	13.3x
Benchmark Median P/E	26.56x
Benchmark Average P/E	80.39x
Benchmark P/E Range	3.47x to 3,385.56x
Company P/B Ratio	1.49x
Benchmark Median P/B	1.81x
Company ROE	48.74%
Benchmark Median ROE	9.91%
Company ROCE	45.53%
Benchmark Median ROCE	12.96%
Company Market Capitalisation	Rs 238.02 crore
Benchmark Median Market Cap	Rs 146.72 crore

Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a P/E ratio of 13.3x, which is below the benchmark median of 26.56x, a difference of -49.92%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a ROE of 48.74%, which is above the benchmark median of 9.91%, a difference of +391.83%. Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a ROCE of 45.53%, which is above the benchmark median of 12.96%, a difference of +251.31%.

Track today's top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Ambalal Sarabhai Enterprises Ltd. operates within the healthcare sector, specifically in the pharmaceuticals and drugs industry. The sector benchmark includes 137 companies, providing a comprehensive overview of the industry's performance. The company's P/E ratio of 13.3 is significantly lower than the industry average of 80.39, suggesting a potential undervaluation compared to its peers.

The sector's P/B ratio median is 1.81, with Ambalal Sarabhai's P/B ratio at 1.49, indicating a competitive position in terms of valuation. The company's ROE of 48.74% and ROCE of 45.53% are well above the industry medians of 9.91% and 12.96%, respectively, highlighting its superior profitability and capital efficiency.

With a market capitalisation of Rs 238.02 crore, Ambalal Sarabhai is positioned below the industry median of Rs 146.72 crore, reflecting its micro-cap status. The company's performance today aligns with broader sector trends, where pharmaceuticals and drugs continue to attract investor interest due to their essential nature and growth potential.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,856.59	30.28	0.44	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,686.76	40.11	8.17	28.21	26.35
Hikal Ltd.	HIKAL	2,676.24	0	2.27	15.22	16.15
Panacea Biotec Ltd.	PANACEABIO	2,540.37	0	3.11	0	5.36
Solara Active Pharma Sciences Ltd.	SOLARA	2,446.19	0	1.91	17.23	15.34

Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a P/E ratio of 13.3x compared with the displayed peer median of 0x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 48.74% compares with a peer median of 15.22% across the companies shown in the table. ROCE stood at 45.53% versus the displayed peer median of 15.34%, providing a capital-efficiency comparison. Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) has a market capitalisation of Rs 238.02 crore. Among the 5 peers shown, 5 have a larger market capitalisation.

In comparison to its peers, Ambalal Sarabhai Enterprises Ltd. exhibits a distinct profile. The company's P/E ratio of 13.3 is notably lower than that of Dishman Carbogen Amcis Ltd. (30.28) and Kwality Pharmaceuticals Ltd. (40.11), indicating a more attractive valuation. Its ROE of 48.74% surpasses peers such as Hikal Ltd. (15.22%) and Panacea Biotec Ltd. (0%), showcasing its strong profitability.

Ambalal Sarabhai's ROCE of 45.53% also outperforms peers like Solara Active Pharma Sciences Ltd. (15.34%) and Sai Parenteral's Ltd. (12.97%), further emphasizing its efficient capital management. The company's market capitalisation of Rs 238.02 crore is smaller compared to larger peers like Dishman Carbogen Amcis Ltd. (Rs 2856.59 crore) and Kwality Pharmaceuticals Ltd. (Rs 2686.76 crore), highlighting its micro-cap status within the industry.

Why Investors Are Watching Ambalal Sarabhai Enterprises Ltd.

Investors are closely monitoring Ambalal Sarabhai Enterprises Ltd. due to its recent price rise and strong fundamental metrics. The company's performance today highlights its potential within the pharmaceuticals and drugs industry.

• Price Action: Share price rose by 11.62% today, exceeding the micro-cap threshold.
• Technical Position: RSI indicates neutral momentum, suggesting balanced market conditions.
• Fundamental Context: Strong ROE and ROCE, with attractive P/E and P/B ratios.
• Sector Positioning: Operates in a competitive industry with growth potential.

Investors should continue to monitor the company's financial performance, sector developments, and market trends to gain further insights into its future trajectory.

About Ambalal Sarabhai Enterprises Ltd.

Ambalal Sarabhai Enterprises Ltd. is a prominent player in the healthcare sector, specifically within the pharmaceuticals and drugs industry. The company focuses on manufacturing and distributing a wide range of pharmaceutical products, catering to diverse medical needs. Its operations are strategically aligned to leverage industry trends and meet the growing demand for healthcare solutions.

With a commitment to innovation and quality, Ambalal Sarabhai aims to enhance its market presence and deliver value to stakeholders. The company's robust financial metrics, including strong profitability and efficient capital management, underscore its competitive position in the industry. As a micro-cap entity, it continues to explore growth opportunities and expand its product offerings to meet evolving market demands.

Track Ambalal Sarabhai Enterprises Ltd. Share Price on Univest

Use Ambalal Sarabhai Enterprises Ltd. (AMBALALSA) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors can track Ambalal Sarabhai Enterprises Ltd. Share Price on Univest for real-time updates and insights. Univest provides comprehensive data on share price movements, technical indicators, fundamental ratios, and shareholding patterns. Users can also access information on 52-week levels and market insights to make informed investment decisions.

Frequently Asked Questions

What is the current share price of Ambalal Sarabhai Enterprises Ltd.?

Ans. The current share price of Ambalal Sarabhai Enterprises Ltd. is Rs 34.48, reflecting an 11.62% increase from the previous close of Rs 30.89. The stock moved 11.62% during the session.

How much did Ambalal Sarabhai Enterprises Ltd. share price rise today?

Ans. The share price of Ambalal Sarabhai Enterprises Ltd. rose by 11.62% today, marking a significant gain in the micro-cap category. The stock moved 11.62% during the session. The intraday range extended from Rs 31.22 to Rs 34.75.

What is the market capitalisation of Ambalal Sarabhai Enterprises Ltd.?

Ans. The market capitalisation of Ambalal Sarabhai Enterprises Ltd. is Rs 238.02 crore, positioning it as a micro-cap company in the healthcare sector. The company operates in the Healthcare sector. Its P/E ratio is 13.3x.

What is the P/E ratio of Ambalal Sarabhai Enterprises Ltd.?

Ans. The P/E ratio of Ambalal Sarabhai Enterprises Ltd. is 13.3, which is lower than the industry average of 80.39, indicating a potentially undervalued status. The company trades at a P/E ratio of 13.3x.

How does Ambalal Sarabhai's ROE compare to its peers?

Ans. Ambalal Sarabhai's ROE of 48.74% is significantly higher than many of its peers, showcasing its strong profitability within the industry. ROE stands at 48.74%. ROCE stands at 45.53%. The relevant peer median ROE is 9.91%.

What sector does Ambalal Sarabhai Enterprises Ltd. operate in?

Ans. Ambalal Sarabhai Enterprises Ltd. operates in the healthcare sector, specifically within the pharmaceuticals and drugs industry. The stock belongs to the Healthcare sector. Its industry classification is Pharmaceuticals & Drugs.